-
DCIS Patients: Your Access to Biomarker Testing is at Risk – Take Action Today
Medicare’s draft policy could take away coverage for DCIS biomarker testing—an important tool that helps patients and doctors make personalized treatment decisions. Without it, patients could face unnecessary treatment, miss critical care, or be forced to make life-changing choices without knowing their tumor biology. Learn why this matters and how you can help protect access for DCIS patients.
-
Experiencing the Power of Community with the PreludeDx Team
When I stepped into the PreludeDx Sales Meeting, I expected to give a talk. What I didn’t expect was to feel like part of a team. This experience reminded me just how powerful patient communities can be—and how companies that truly listen to patients can make a real impact.
-
DIEP Flap Insurance Coverage at Risk: Urgent Advocacy Issue
Insurance coverage for DIEP flap reconstruction is in danger because of a CMS coding change. Take action today to advocate for our options. Together we can make a difference.
-
Persisting Towards a Diagnosis: From Carpal Tunnel to a Herniated Disc
Adventures in Self-Advocacy-- The real reason my fingers were numb was a herniated disc in my spine, not carpal tunnel.
